300421.SZ(300421.SZ)
300421.SZ
No analyst ratings available
No analyst price targets available for 300421.SZ
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q1 2028 |
|---|---|---|---|---|---|---|
| Revenue Avg | $270M | $272M | $274M | $277M | $279M | $283M |
| Low | $270M | $272M | $274M | $277M | $279M | $283M |
| High | $270M | $272M | $274M | $277M | $279M | $283M |
| EBITDA Avg | $42M | $42M | $43M | $43M | $43M | $44M |
| Low | $42M | $42M | $43M | $43M | $43M | $44M |
| High | $42M | $42M | $43M | $43M | $43M | $44M |
| EBIT Avg | $21M | $21M | $22M | $22M | $22M | $22M |
| Low | $21M | $21M | $22M | $22M | $22M | $22M |
| High | $21M | $21M | $22M | $22M | $22M | $22M |
| Net Income Avg | $22M | $34M | $22M | $27M | $53M | $53M |
| Low | $22M | $34M | $22M | $27M | $53M | $53M |
| High | $22M | $34M | $22M | $27M | $53M | $53M |
| EPS Avg | $0.07 | $0.12 | $0.07 | $0.09 | $0.18 | $0.18 |
| Low | $0.07 | $0.12 | $0.07 | $0.09 | $0.18 | $0.18 |
| High | $0.07 | $0.12 | $0.07 | $0.09 | $0.18 | $0.18 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |